The first in a series of interviews with staff members of the Office of the U.S. Global AIDS Coordinator, responsible for the U.S. President’s Emergency Plan for AIDS Relief program, Science Speaks sat down with Caroline Ryan, MD, MPH. As Director of Technical Leadership at OGAC, Dr. Ryan has been a long-time key architect of PEPFAR’s implementation, first […]
This is the first in a week-long series exploring efforts to reduce HIV incidence via scaling up medical male circumcision (MC) in sub-Saharan Africa. Clinical trials have shown MC protects males by up to 60 percent from contracting HIV during vaginal sex. For more information, check out the Center’s recent report “Medical Male Circumcision as […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]